LFB strategic transformation project
LFB strategic transformation project
LFB presents its strategic transformation project paving the way for future growth:
LFB completes the sale of CELLforCURE to Novartis
LFB completes the sale of CELLforCURE to Novartis
The completion of the sale comes as part of LFB’s strategy to refocus on its core business – medicinal products derived from plasma or recombinant proteins
Les Ulis (France), 1st April 2019 – LFB announces the completion of the sale of CELLforCURE to Novartis.
LFB joins World Hemophilia Day 2019!
LFB joins the World Hemophilia Day 2019, today April 17th.
Discover the 2019 LFB corporate vidéo
April 26th, 2019
Discover the 2019 LFB corporate video
https://www.groupe-lfb.com/en/news/2019-lfb-corporate-video/